These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

705 related articles for article (PubMed ID: 34943685)

  • 41. Current approaches for the exploration of antimicrobial activities of nanoparticles.
    Rosli NA; Teow YH; Mahmoudi E
    Sci Technol Adv Mater; 2021; 22(1):885-907. PubMed ID: 34675754
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Degradable antimicrobial polycarbonates with unexpected activity and selectivity for treating multidrug-resistant Klebsiella pneumoniae lung infection in mice.
    Yang C; Lou W; Zhong G; Lee A; Leong J; Chin W; Ding B; Bao C; Tan JPK; Pu Q; Gao S; Xu L; Hsu LY; Wu M; Hedrick JL; Fan W; Yang YY
    Acta Biomater; 2019 Aug; 94():268-280. PubMed ID: 31129359
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nanoparticles-Attractive Carriers of Antimicrobial Essential Oils.
    Nair A; Mallya R; Suvarna V; Khan TA; Momin M; Omri A
    Antibiotics (Basel); 2022 Jan; 11(1):. PubMed ID: 35052985
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nanotechnology as a therapeutic tool to combat microbial resistance.
    Pelgrift RY; Friedman AJ
    Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1803-15. PubMed ID: 23892192
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Multidrug-Resistant Pathogens in Burn Wound, Prevention, Diagnosis, and Therapeutic Approaches (Conventional Antimicrobials and Nanoparticles).
    Hemmati J; Azizi M; Asghari B; Arabestani MR
    Can J Infect Dis Med Microbiol; 2023; 2023():8854311. PubMed ID: 37521436
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Promising advances in nanobiotic-based formulations for drug specific targeting against multidrug-resistant microbes and biofilm-associated infections.
    Elfadil D; Elkhatib WF; El-Sayyad GS
    Microb Pathog; 2022 Sep; 170():105721. PubMed ID: 35970290
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cracking the Challenge of Antimicrobial Drug Resistance with CRISPR/Cas9, Nanotechnology and Other Strategies in ESKAPE Pathogens.
    Zohra T; Numan M; Ikram A; Salman M; Khan T; Din M; Salman M; Farooq A; Amir A; Ali M
    Microorganisms; 2021 Apr; 9(5):. PubMed ID: 33946643
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Rhamnolipid-Coated Iron Oxide Nanoparticles as a Novel Multitarget Candidate against Major Foodborne E. coli Serotypes and Methicillin-Resistant S. aureus.
    Sharaf M; Sewid AH; Hamouda HI; Elharrif MG; El-Demerdash AS; Alharthi A; Hashim N; Hamad AA; Selim S; Alkhalifah DHM; Hozzein WN; Abdalla M; Saber T
    Microbiol Spectr; 2022 Aug; 10(4):e0025022. PubMed ID: 35852338
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Alternatives Therapeutic Approaches to Conventional Antibiotics: Advantages, Limitations and Potential Application in Medicine.
    Alaoui Mdarhri H; Benmessaoud R; Yacoubi H; Seffar L; Guennouni Assimi H; Hamam M; Boussettine R; Filali-Ansari N; Lahlou FA; Diawara I; Ennaji MM; Kettani-Halabi M
    Antibiotics (Basel); 2022 Dec; 11(12):. PubMed ID: 36551487
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Strategies to prevent the occurrence of resistance against antibiotics by using advanced materials.
    Bassegoda A; Ivanova K; Ramon E; Tzanov T
    Appl Microbiol Biotechnol; 2018 Mar; 102(5):2075-2089. PubMed ID: 29392390
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Factors pivotal for designing of nanoantimicrobials: an exposition.
    Jamil B; Imran M
    Crit Rev Microbiol; 2018 Feb; 44(1):79-94. PubMed ID: 28421881
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Molecular characterization of virulence and drug resistance genes-producing Escherichia coli isolated from chicken meat: Metal oxide nanoparticles as novel antibacterial agents.
    Ali SS; Sonbol FI; Sun J; Hussein MA; Hafez AE; Abdelkarim EA; Kornaros M; Ali A; Azab M
    Microb Pathog; 2020 Jun; 143():104164. PubMed ID: 32198092
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Biogenic Silver Nanoparticles as a Strategy in the Fight Against Multi-Resistant
    Estevez MB; Casaux ML; Fraga M; Faccio R; Alborés S
    Front Bioeng Biotechnol; 2021; 9():644014. PubMed ID: 33981689
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Plant-derived nanoparticles as alternative therapy against Diarrheal pathogens in the era of antimicrobial resistance: A review.
    Abolarinwa TO; Ajose DJ; Oluwarinde BO; Fri J; Montso KP; Fayemi OE; Aremu AO; Ateba CN
    Front Microbiol; 2022; 13():1007115. PubMed ID: 36590407
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Demand for New Antibiotics: Antimicrobial Peptides, Nanoparticles, and Combinatorial Therapies as Future Strategies in Antibacterial Agent Design.
    León-Buitimea A; Garza-Cárdenas CR; Garza-Cervantes JA; Lerma-Escalera JA; Morones-Ramírez JR
    Front Microbiol; 2020; 11():1669. PubMed ID: 32793156
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Engineered Nanoparticles with Antimicrobial Property.
    Reshma VG; Syama S; Sruthi S; Reshma SC; Remya NS; Mohanan PV
    Curr Drug Metab; 2017; 18(11):1040-1054. PubMed ID: 28952436
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prospects of Exploring the Metal-Organic Framework for Combating Antimicrobial Resistance.
    Polash SA; Khare T; Kumar V; Shukla R
    ACS Appl Bio Mater; 2021 Dec; 4(12):8060-8079. PubMed ID: 35005933
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Breaking antimicrobial resistance by disrupting extracytoplasmic protein folding.
    Furniss RCD; Kaderabkova N; Barker D; Bernal P; Maslova E; Antwi AAA; McNeil HE; Pugh HL; Dortet L; Blair JMA; Larrouy-Maumus G; McCarthy RR; Gonzalez D; Mavridou DAI
    Elife; 2022 Jan; 11():. PubMed ID: 35025730
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.